News & Perspective

Sep 20, 2012

Sep 20, 2012

ECDC studies shed new light on narcolepsy and H1N1 vaccine

(CIDRAP News) – The European Centre for Disease Prevention and Control (ECDC) today confirmed a link between narcolepsy and pandemic 2009 H1N1 vaccination in children in Finland and Sweden, the two countries that originally reported a problem with the vaccine.

Sep 01, 2011

Sep 01, 2011

Probe on narcolepsy-H1N1 vaccine link finds genetic risk factor

(CIDRAP News) – A final report from Finnish health officials on the link between the 2009 H1N1 Pandemrix vaccine and narcolepsy confirmed the link, finding a greater risk than their earlier estimate and identifying a genetic risk factor in all patients.

Jan 18, 2011

Jan 18, 2011

Northern Hemisphere countries show steady rise in flu

(CIDRAP News) – Flu activity is increasing in many of the Northern Hemisphere's temperate-zone countries, with influenza B cocirculating with the 2009 pandemic H1N1 virus across Europe and teaming up with influenza A (H3N2) in the United States and Canada, the World Health Organization (WHO) said in its latest update.

Jul 07, 2010

Jul 07, 2010

Non-vaccine aid for needy nations' pandemic response falls short

(CIDRAP News) – While donor countries and organizations have responded well to the need for pandemic flu vaccine for developing countries, the level of giving for other pandemic response efforts in needy countries so far has fallen short, the World Health Organization (WHO) said in a recent report.

Nov 04, 2009

Nov 04, 2009

H1N1 FLU BREAKING NEWS: OTC antivirals, Ukraine aid, Amazon tribe struck, pain relievers and vaccine, cat has H1N1

 

Norway OKs OTC antiviral salesTo ease response to the H1N1 pandemic, Norway is allowing over-the-counter sales of oseltamivir (Tamiflu) and zanamivir (Relenza), the Associated Press (AP) reported. The new policy starts tomorrow and is in effect until the middle of 2010. Norway has ordered 9.4 million doses of vaccine, but the manufacturer has reportedly not produced enough to meet demand.

Sep 05, 2008

Sep 05, 2008

Dutch patient dies from Tamiflu-resistant H1N1 virus

(CIDRAP News) – Amid concern about rising resistance to oseltamivir (Tamiflu) in influenza A/H1N1 viruses, a Dutch team this week reported the death of a leukemia patient who was infected with an H1N1 virus that was resistant to the antiviral drug.

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation 3MAccelerate DiagnosticsGilead 
Grant support for ASP provided by


bioMérieux

  Become an underwriter»